May 26, 2015

Approval for Additional Pediatric Indications in Japan Received for TALION® Tablets and TALION® OD Tablets, Anti-Allergic Agents
Mitsubishi Tanabe Pharma Corporation and Ube Industries, Ltd. announced today that Mitsubishi Tanabe Pharma has received approval of a partial change of approved information for TALION® Tablets and TALION® OD Tablets , Anti-Allergic Agents. The partial change is related to additional pediatric indications.
High-dispersion strontium carbonate nano particles viewed under a scanning electron microscope

May 14, 2015

UBE Develops High-Dispersion Strontium Carbonate Nano Particles
Ube Industries, Ltd. announced today that it has succeeded in synthesizing the world's first high-dispersion strontium carbonate nano particles for optical applications.

May 12, 2015

Consolidated Financial Report for the Fiscal Year Ended March 31, 2015 PDF (PDF:128KB)
Ube Industries Announces Consolidated Financial Report for the Fiscal Year Ended March 31, 2015